NEWARK, Del., USA | April 16, 2026 — According to the latest insights by Future Market Insights, the global advance renal cell carcinoma therapeutics market is entering a steady growth trajectory as oncology treatment paradigms evolve toward combination regimens. The market is valued at USD 7.80 billion in 2026 and is projected to reach USD 13.20 billion by 2036, expanding at a CAGR of...
The Digital Therapeutics market is reshaping how healthcare delivers treatment. Unlike general wellness apps, digital therapeutics (DTx) provide evidence-based therapeutic interventions driven by software. Physicians prescribe some of them. Regulators review many of them. And patients increasingly rely on them for managing chronic conditions.
From diabetes management platforms to...
NEWARK, DE/ 2/April/2026— The global equine veterinary therapeutics market is set for steady expansion, projected to grow from USD 1,572.6 million in 2025 to USD 3,047.6 million by 2035, registering a CAGR of 6.8% over the forecast period, according to Future Market Insights (FMI). Growth is being fueled by increasing investment in equine healthcare, the rising economic value of...
NEWARK, DE | The Exosome-Based Neurodegenerative Disease Therapeutics Market, valued at USD 25.9 million in 2025, is projected to reach USD 32.8 million in 2026 and expand rapidly to USD 352.5 million by 2036, registering a CAGR of 26.80% during the forecast period. This growth reflects a structural shift in neurology drug development, as traditional small molecules fail to cross the...
The global custom antibody services market is experiencing strong expansion, driven by increasing demand for precision medicine, rising prevalence of chronic diseases, and rapid advancements in biotechnology and life sciences research. The market size is projected to reach US$ 1,216.35 million by 2031, rising from US$ 590.33 million in 2023, reflecting a steady growth trajectory. During the...
Hepatitis therapeutics has entered a decisive phase of transformation, driven by scientific innovation, expanded access strategies, and a stronger global commitment to viral elimination. As healthcare systems evolve, the focus is no longer limited to managing infection but increasingly aims at functional cures, long-term suppression, and improved patient quality of life. This shift is...
Leukemia therapeutics has entered a transformative phase, driven by rapid scientific advances and a deeper understanding of cancer biology. As treatment paradigms evolve, the focus has shifted from generalized chemotherapy toward more precise, targeted, and immune-based approaches. Today’s leukemia treatment landscape reflects a convergence of innovation, personalization, and improved...
The Expanding Role of mHealth in a Digital-First Healthcare Ecosystem
The rapid evolution of mHealth—short for mobile health—has become one of the most transformative shifts in modern healthcare. As a core component of digital health, mHealth refers to the use of smartphones, wearable devices, and wireless technologies to deliver healthcare services, monitor patients, and promote...
The medical world is currently witnessing a shift as profound as the discovery of antibiotics or the invention of the X-ray. At the heart of this revolution is Messenger RNA (mRNA). Once a niche area of molecular biology, mRNA has surged into the global spotlight, transforming from a "promising concept" to a multi-billion-dollar powerhouse.
In this in-depth market analysis, we explore the...
The medical world is currently witnessing a shift as profound as the discovery of antibiotics or the invention of the X-ray. At the heart of this revolution is Messenger RNA (mRNA). Once a niche area of molecular biology, mRNA has surged into the global spotlight, transforming from a "promising concept" to a multi-billion-dollar powerhouse.
In this in-depth market analysis, we explore the...
Russian 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Tiếng Việt